{"url_path":"/sec/ahco/8-k/2026-06-22/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1725255/0001104659-26-076390-index.html","accession_number":"0001104659-26-076390","cik":"0001725255","ticker":"AHCO","issuer_name":"AdaptHealth Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725255/0001104659-26-076390-index.html","primary_entity_key":"0001725255","primary_entity_name":"AdaptHealth Corp."},"word_count":501,"has_tables":true,"body_markdown":"**Item 5.07.**\n**Submission of Matters to a Vote of Security Holders.**\n\n \n\nOn June 18, 2026, AdaptHealth\nCorp. (the “Company”) held the annual meeting of stockholders (the “Annual Meeting”) of the Company via live\naudio webcast. At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail\nin the Company’s definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April\n28, 2026. At the beginning of the Annual Meeting, there were 120,652,493 shares of common stock of the Company, par value $0.0001 per\nshare (“Common Stock”) present or represented by proxy at the Annual Meeting, which represented 88.67% of the voting power\nof the shares of Common Stock entitled to vote at the Annual Meeting, and which constituted a quorum for the transaction of business.\nHolders of the Company’s Common Stock were entitled to one vote for each share of Common Stock held as of the close of business\non April 24, 2026, the record date for the Annual Meeting.\n\n \n\nThe stockholders of the Company\nvoted on the following proposals at the Annual Meeting:\n\n \n\n1. To elect nine directors\nfor a one-year term;\n\n \n\n2. To ratify the appointment of KPMG\nLLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; and\n\n \n\n3. A non-binding advisory vote to approve\nthe compensation paid to the Company’s named executive officers.\n\n \n\nThe voting results for each\nof these proposals are set forth below.\n\n \n\n1.\nElection of Directors.\n\n \n\n**Name**\n \n**For**\n \n**Withheld**\n \n**Broker Non-Vote**\n\nGregory Belinfanti\n \n106,611,172\n \n2,165,500\n \n11,875,821\n\nTerence Connors\n \n106,470,008\n \n2,306,664\n \n11,875,821\n\nBrad Coppens\n \n107,111,674\n \n1,664,998\n \n11,875,821\n\nSuzanne Foster\n \n105,992,570\n \n2,784,102\n \n11,875,821\n\nTed Lundberg\n \n102,690,918\n \n6,085,754\n \n11,875,821\n\nKenneth A. Samet\n \n108,390,299\n \n386,373\n \n11,875,821\n\nDr. Susan Weaver\n \n106,714,121\n \n2,062,551\n \n11,875,821\n\nDavid Williams III\n \n106,543,756\n \n2,232,916\n \n11,875,821\n\nDale Wolf\n \n105,844,287\n \n2,932,385\n \n11,875,821\n\n \n\nBased on the votes set forth\nabove, each director nominee was duly elected to serve as a director until the Company’s annual meeting of stockholders in 2027,\nor until their respective successors are duly elected and qualified, or until their earlier resignation, removal or death.\n\n \n\n- 2 -\n\n \n\n \n\n2.\nRatification of Appointment of Independent Registered Public Accounting Firm.\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n\n119,090,024\n \n1,092,126\n \n470,343\n\n \n\nBased on the votes set forth\nabove, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for\nthe fiscal year ending December 31, 2026.\n\n \n\n3.\nNon-binding advisory vote to approve the compensation paid to the Company’s named executive\nofficers.\n\n \n\n**For**\n \n**Against**\n \n**Abstain**\n \n**Broker Non-Vote**\n\n107,129,368\n \n965,272\n \n682,032\n \n11,875,821\n\n \n\nBased on the votes set forth\nabove, the stockholders approved this proposal on an advisory basis.\n\n \n\n- 3 -\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned\nhereunto duly authorized.\n\n \n\nDated: June 22, 2026\n\n \n\nAdaptHealth Corp.\n \n\n \n \n\nBy:\n/s/ Richard\nRew\n \n\n \nName:\nRichard Rew\n \n\n \nTitle:\nChief Legal Officer, General Counsel and Secretary\n \n\n \n\n- 4 -"}